By: Christopher A. Parrella, Esq., CPC, CHC, CPCO
Parrella Health Law, Boston, Ma.
A Health Law Defense and Compliance Firm

In a pivotal case, the Connecticut Appellate Court has firmly supported employers’ rights to enforce workplace policies prohibiting impairment by medical marijuana, emphasizing the significance of maintaining safety and integrity within the work environment. The court’s decision in Bartolotta v. Human Resources of New Britain, Inc. offers crucial insights into the balance between employee rights under the Connecticut Palliative Use of Marijuana Act (PUMA) and an employer’s prerogative to uphold a drug-free workplace.

The case involved a teaching assistant at Human Resources of New Britain, Inc., who, despite having a medical marijuana card, was terminated for being impaired at work due to marijuana use. This incident sparked a legal battle over whether the employer’s actions violated PUMA or the Urinalysis Drug Testing Statute. The court’s findings elucidated two critical aspects: the scope of protection afforded by PUMA and the standards for “reasonable suspicion” drug testing.

Reaffirmation of Employers’ Rights under PUMA
The court underscored that PUMA’s protections are narrowly construed, shielding employees from discrimination solely based on their status as medical marijuana patients. However, these protections do not extend to permitting impairment in the workplace. The ruling reaffirms that employers are not obliged to compromise workplace safety or violate federal law by allowing on-the-job impairment, even if the employee is a certified medical marijuana user. This decision aligns with the principle that employee health and safety, alongside compliance with both state and federal regulations, are paramount in maintaining a productive and secure work environment.

Clarification on Reasonable Suspicion for Drug Testing
A significant portion of the court’s decision provided clarity on the “reasonable suspicion” standard required for lawful drug testing under Connecticut law. Drawing parallels with Fourth Amendment jurisprudence, the court detailed that reasonable suspicion must be based on specific, articulable facts leading a reasonable person to believe that an employee might be impaired. This standard underscores the importance of objective, evidence-based assessments in justifying drug tests, ensuring that employers have a solid factual basis for their actions.

In Bartolotta, the combination of observed behavior, admissions of medical marijuana use, and the timing and context of these admissions furnished the employer with sufficient grounds for reasonable suspicion. This aspect of the ruling is particularly instructive for employers, highlighting the necessity for careful observation, thorough investigation, and meticulous documentation when addressing suspected impairment in the workplace.

Implications for Employers
The Connecticut Appellate Court’s decision serves as a vital guideline for employers navigating the complexities of drug policies in the era of medical marijuana. It emphasizes the need for clear, comprehensive policies that articulate the consequences of impairment at work and establish procedures for drug testing based on reasonable suspicion.

At Parrella Health Law, we understand the intricacies of maintaining compliance with both state medical marijuana laws and federal regulations. This case reinforces the importance of having well-drafted policies and training for managers and HR professionals to identify impairment and conduct investigations sensitively and legally. Our team is equipped to assist healthcare providers and employers in developing policies that respect employee rights while prioritizing patient and workplace safety.

For organizations seeking to navigate these complex legal landscapes, Parrella Health Law offers expert guidance and support. Ensuring your policies reflect the latest legal standards is crucial in protecting your organization and upholding the highest levels of workplace safety and integrity. Please call us at 857-328-0382 or send an email to me at cparrella@parrellahealthlaw.com.

Christopher Parrella, ESQ, CPC, CHC, CPCO, is the founding partner of Parrella Health Law in Boston, Mass. The firm focuses exclusively on healthcare defense and compliance matters. Chris also travels the country on behalf of a wide range of healthcare organizations, lecturing on a variety of health care enforcement and compliance topics. Chris is one of a handful of health care attorney’s that are also Certified Professional Coders (CPC) and is a member of the AAPC’s National Legal Advisory Board and Ethics Committee.  He is also a Certified Professional Compliance Officer (CPCO) and Certified in Health Care Compliance (CHC.)